Lexington – Delays in cancer diagnosis and treatment that occurred during the first two years of the COVID-19 pandemic led to a decline in 1-year survival rates in the US, according to an analysis of the US cancer registry SEER 21 published in JAMA Oncology (2026; DOI: 10.1001/jamaoncol.2025.6332). During the...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Lexington – Delays in cancer diagnosis and treatment that occurred during the first two years of the COVID-19 pandemic led to a decline in 1-year survival rates in the US, according to an analysis of the US cancer registry SEER 21 published in JAMA Oncology (2026; DOI: 10.1001/jamaoncol.2025.6332). During the...